Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE)

Clinical trial NCT04252937 · UNKNOWN

Trial details

NCT number: NCT04252937
Sponsor: GREAT Network Italy
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Heart Failure

Start date: 2019-12-15
Primary completion: 2021-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.